Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.
| Last: | $7.745 |
|---|---|
| Change Percent: | -2.82% |
| Open: | $8.18 |
| Close: | $7.97 |
| High: | $8.3999 |
| Low: | $7.7101 |
| Volume: | 62,499 |
| Last Trade Date Time: | 02/27/2026 12:43:16 pm |
| Market Cap: | $168,243,331 |
|---|---|
| Float: | 10,323,432 |
| Insiders Ownership: | 0.28% |
| Institutions: | 35 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.cartesiantherapeutics.com |
| Country: | US |
| City: | Frederick |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Cartesian Therapeutics Inc. (NASDAQ: RNAC).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
